55.82
0.25%
+0.14
After Hours:
55.7504
-0.0696
-0.12%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
CVS Health Corp stock is currently priced at $55.82, with a 24-hour trading volume of 9.18M.
It has seen a +0.25% increased in the last 24 hours and a -21.55% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $55.38 pivot point. If it approaches the $56.04 resistance level, significant changes may occur.
Previous Close:
$55.68
Open:
$55.72
24h Volume:
9.18M
Market Cap:
$70.07B
Revenue:
$360.94B
Net Income/Loss:
$7.32B
P/E Ratio:
8.4193
EPS:
6.63
Net Cash Flow:
$8.14B
1W Performance:
-0.14%
1M Performance:
-21.55%
6M Performance:
-17.52%
1Y Performance:
-19.93%
CVS Health Corp Stock (CVS) Company Profile
Name
CVS Health Corp
Sector
Industry
Phone
401-765-1500
Address
One CVS Drive, Woonsocket
CVS Health Corp Stock (CVS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-06-24 | Initiated | Barclays | Equal Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Dec-22-23 | Initiated | HSBC Securities | Buy |
Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
May-26-23 | Initiated | Piper Sandler | Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-14-21 | Initiated | Goldman | Buy |
Dec-01-21 | Initiated | Seaport Research Partners | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
Sep-17-20 | Initiated | Piper Sandler | Overweight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-18-19 | Initiated | Guggenheim | Buy |
Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-10-19 | Reiterated | BofA/Merrill | Buy |
Mar-13-19 | Initiated | Bernstein | Outperform |
Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Jan-17-19 | Initiated | UBS | Buy |
Dec-18-18 | Initiated | Barclays | Overweight |
Nov-29-18 | Resumed | Goldman | Neutral |
Nov-28-18 | Initiated | Evercore ISI | Outperform |
Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
CVS Health Corp Stock (CVS) Latest News
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Invest Smart: 2 Blue Chips To Buy When Others Are Scared
Seeking Alpha
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Zacks Investment Research
Pilgrim's and CVS Health have been highlighted as Zacks Bull and Bear of the Day
Zacks Investment Research
Bear of the Day: CVS Health (CVS)
Zacks Investment Research
From Apple to Wayfair: A Lot of Earnings Results to Cover
The Motley Fool
CVS Health Corp Stock (CVS) Financials Data
CVS Health Corp (CVS) Revenue 2024
CVS reported a revenue (TTM) of $360.94 billion for the quarter ending March 31, 2024, a +9.07% rise year-over-year.
CVS Health Corp (CVS) Net Income 2024
CVS net income (TTM) was $7.32 billion for the quarter ending March 31, 2024, a +78.87% increase year-over-year.
CVS Health Corp (CVS) Cash Flow 2024
CVS recorded a free cash flow (TTM) of $8.14 billion for the quarter ending March 31, 2024, a -53.20% decrease year-over-year.
CVS Health Corp (CVS) Earnings per Share 2024
CVS earnings per share (TTM) was $5.69 for the quarter ending March 31, 2024, a +83.55% growth year-over-year.
CVS Health Corp Stock (CVS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Mahoney Michael F | Director |
May 02 '24 |
Buy |
54.49 |
9,181 |
500,294 |
9,356 |
LUDWIG EDWARD J | Director |
May 02 '24 |
Buy |
53.88 |
1,000 |
53,879 |
21,630 |
Shah Prem S | EVP and Pres-Pharm, Consumer W |
Feb 16 '24 |
Sale |
76.95 |
29,473 |
2,267,947 |
39,765 |
LUDWIG EDWARD J | Director |
Nov 03 '23 |
Buy |
70.47 |
2,000 |
140,930 |
20,630 |
Clark James David | SVP, Cont & Chief Acct Officer |
Aug 03 '23 |
Sale |
74.92 |
25,759 |
1,930,004 |
4,698 |
About CVS Health Corp
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Cap:
|
Volume (24h):